Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

This ground-breaking first procedure not only marks the launch of the THOR ... laser catheter integrates two critical PAD treatments into a single device, significantly simplifying the treatment ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery ...